Moncef Slaoui is the chief adviser for Operation Warp Speed, the Trump administration project to find a vaccine for the coronavirus (COVID-19). He has been described as Trump’s “vaccine czar.” It has been revealed that Slaoui is in a position to financially benefit from the project he is overseeing. The revelation exposes yet another possible conflict of interest scandal for the Trump administration.
> More Donald Trump Scandals
Slaoui was on the board of directors for Moderna. Moderna is a $30 billion biotech firm based in Cambridge, Massachusetts. They are pursuing the virus vaccine.
Since being announced as the Operation Warp Speed head, Slaoui’s investment in Moderna increased by $2.4 million, to a total of $12.4 million. When Trump put him in charge of the project, he came on as a contract worker and not a government employee, which exempts him from federal disclosure requirements.
After the holdings were reported on, Slaoui announced through the Department of Health and Human Services that he would divest.
Slaoui was also an executive at GlaxoSmithKline, and does not want to sell his holdings of that firm.
Operation Warp Speed
Trump formally announced the creation of “Operation Warp Speed” in a May 15, 2020 speech at the White House.